Randomized Trial of Lower-Dose Roxadustat Efficacy and Safety in Non–Dialysis-Dependent CKD-Associated Anemia

Introduction: Different starting doses of roxadustat are used for treating anemia in chronic kidney disease (CKD). We tested the noninferiority of weight-based lower starting dose compared with standard starting dose roxadustat for anemia in stage 3 to 5 CKD without dialysis. Methods: Patients were...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Ping Li, Xuefeng Sun, Li Zhang, Hongli Lin, Niansong Wang, Yuehong Li, Sumei Zhao, Ping Fu, Hong Cheng, Zhiyong Guo, Wanhong Lu, Yani He, Fengmin Shao, Qiang He, Yiqing Wu, Cuihua Huang, Shuting Pan, Guangyan Cai, Xiangmei Chen, Shiren Sun, Wei Liang, Hongtao Yang, Zhaohui Ni, Qiongqiong Yang, Wenge Li, Aihua Zhang, Guojuan Zhang, Gengru Jiang, Bo Lin, Yanning Zhang, Wenhu Liu, Yonghui Mao, Jinsheng Xu, Weiping Liu, Song Wang, Xiaodong Zhang, Jurong Yang, Hongwei Jiang
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-04-01
סדרה:	Kidney International Reports
נושאים:	anemia chronic kidney disease efficacy hemoglobin variability roxadustat
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S246802492500052X
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!